Sacramento, CA · Founded 2016 · Privately Held (backing)
Developer of biotechnology drugs designed to offer a potential treatment to protect the nervous system from multiple sclerosis damage. Therini Bio is based in Sacramento, CA and was founded in 2016. It was valued at $100 million at its later-stage round in May 2025, the last priced event on record. It has raised $102 million across 2 recorded rounds; the latest was a $74.9 million later-stage round in Mar 2023.
PMV mark · valuation
$100.0M
Oct 2026
Priced at
its later-stage round
May 2025
Total raised
$101.5M
Last round
Later Stage VC
Mar 2023
No prints on record
No secondary trades in Therini Bio shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Therini Bio with a free account
·The complete investor list: 15 names
·Watch Therini Bio: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Therini Bio stock.
